Delivery of Health Care; Digestive System Diseases; Carcinoma, Hepatocellular; Translational Medical Research
Public Health Interests
Health Care Quality; Health Services Research
Dr. Taddei has built clinical programs at Yale and the VA with a focus on multidisciplinary, integrated care of the patient with liver cancer. In 2009, she developed the VA Connecticut Liver Tumor Board, now a regional tumor board serving VA Medical Centers in Connecticut, Providence, and Central Western Massachusetts. In 2011, she oversaw the accreditation of the Yale Liver Tumor Board, approved by the Smilow Cancer Hospital at Yale New Haven's Cancer Committee to meet all requirements of accreditation by the American College of Surgeons. She is funded by the VA National Center for Patient Safety and the VA Office of HIV, Hepatitis and Related Conditions Programs for national implementation of the Cancer Care Tracking System, a locally developed tool to improve liver cancer detection and comprehensive care. She is co-Principal Investigator on a national VA study of outcomes in Veterans with liver cancer. She collaborates on several translational projects that seek to understand the biology of liver cancer to inform prognosis and targets for treatment.
Specialized Terms: Clinical, translational, and outcome research on hepatocellular carcinoma
Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
Kaplan DE, Chapko MK, Mehta R, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Pocha C, Valderrama A, Taddei TH; VOCAL Study Group. Clin Gastroenterol Hepatol. 2017 Jul 26. pii: S1542-3565(17)30861-3. doi: 10.1016/j.cgh.2017.07.024. [Epub ahead of print]
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M, Taddei TH, Mehta R, D'Addeo K, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Goldberg DS, Valderrama A, Kaplan DE; VOCAL Study Group. Gastroenterology. 2017 Jun;152(8):1954-1964. doi: 10.1053/j.gastro.2017.02.040. Epub 2017 Mar 7
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS, Taddei TH, Serper M, Mehta R, Dieperink E, Aytaman A, Baytarian M, Fox R, Hunt K, Pedrosa M, Pocha C, Valderrama A, Kaplan DE. Hepatology. 2017 Mar;65(3):864-874. doi: 10.1002/hep.28765. Epub 2016 Oct 5.
Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
Langberg KM, Taddei TH. Hepatology. 2016;64(4):1014-6.
Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis
Kaplan DE, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Knott A, Mehta R, Pedrosa M, Pocha C, Valderrama A, Taddei T; VOCAL Study Group. Dig Dis Sci. 2016; 61:3309-3320.
HIV, Aging, and Viral Coinfections: Taking the Long View.
Taddei TH, Lo Re V 3rd, Justice AC. Curr HIV/AIDS Rep. 2016;13(5):269-78.
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score from a National Electronic Healthcare Database.
Kaplan DE, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Knott A, Pedrosa M, Pocha C, Mehta R, Duggal M, Skanderson M, Valderrama A, Taddei TH; VOCAL Study Group. Clin Gastroenterol Hepatol. 2015: 2015 Dec;13(13):2333-41.e1-6.